Aberrant protein expression in plasma and kidney tissue during experimental obstructive nephropathy

Proteomics - Clinical Applications

Volumn 3, Issue 10, 2009, Pages 1211-1224

  Giannakis, Eleni ^a   Samuel, Chrishan S ^a   Hewitson, Tim D ^a,b   Boon, Wee Ming ^c   Macris, Mary ^a   Reeve, Shane ^c   Lawrence, Josie ^c   Smith, A Ian ^c   Tregear, Geoffrey W ^a   Wade, John D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

2 D; Protein profiling; Renal fibrosis; SELDI TOF MS; Unilateral uretric obstruction

Indexed keywords

ALPHA ENOLASE; FIBRINOGEN; HAPTOGLOBIN; MALATE DEHYDROGENASE; RAS LIKE ACTIVATOR PROTEIN; REGULATOR PROTEIN; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY PARENCHYMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSTRUCTIVE NEPHROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANIMALIA; MURINAE;

EID: 70350774534     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200900021     Document Type: Article

References (36)

1. Provoost, A. P., Molenaar, J. C., Renal function during and after a temporary complete unilateral ureter obstruction in rats. Invest. Urol. 1981, 18, 242-246.
2. Chevalier, R. L., Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2006, 2, 157-168.
3. Chevalier, R. L., Peters, C. A., Congenital urinary tract obstruction: Proceedings of The State-of-The-Art Strategic Planning Workshop. National Institutes of Health, Bethesda, MD, USA, 11-12, March 2002. Pediatr. Nephrol. 2003, 18, 576-606.
4. Lemley, K. V., An introduction to biomarkers: applications to chronic kidney disease. Pediatr. Nephrol. 2007, 22, 1849-1859.
5. Klahr, S., Morrissey, J., Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal. Physiol. 2002, 283, F861-F875.
6. Diamond, J. R., Ricardo, S. D., Klahr, S., Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin. Nephrol. 1998, 18, 594-602.
7. Hewitson, T. D., Mookerjee, I., Masterson, R., Zhao, C. et al., Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinology 2007, 148, 660-669.
8. Becker, G. J., Hewitson, T. D., The role of tubulointerstitial injury in chronic renal failure. Curr. Opin. Nephrol. Hypertens. 2000, 9, 133-138.
9. Giannakis, E., Samuel, C. S., Boon, W. M., Macris, M. et al., SELDI-TOF mass spectrometry-based protein profiling of kidney tissue. Methods Mol. Biol. 2009, 466, 237-249.
10. Buzza, M. S., Zamurs, L., Sun, J., Bird, C. H. et al., Extra-cellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J. Biol. Chem. 2005, 280, 23549-23558.
11. Decramer, S., Wittke, S., Mischak, H., Zurbig, P. et al., Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 2006, 12, 398-400.
12. Kypreou, K. P., Kavvadas, P., Karamessinis, P., Peroulis, M. et al., Altered expression of calreticulin during the development of fibrosis. Proteomics 2008, 8, 2407-2419.
13. O'Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O. et al., Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 2004, 50, 1788-1799.
14. Mullan, R. H., Bresnihan, B., Golden-Mason, L., Markham, T. et al., Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum. 2006, 54, 105-114.
15. Hartmann, A., Eide, T. C., Fauchald, P., Bentdal, O. et al., Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection. Nephrol. Dial. Transplant. 1997, 12, 161-166.
16. Denk, G. U., Cai, S. Y., Chen, W. S., Lin, A. et al., A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology. World J. Gastroenterol. 2006, 12, 2536-2548.
17. Kim, J. H., Ha, I. S., Hwang, C. I., Lee, Y. J. et al., Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease. Kidney Int. 2004, 66, 1826-1837.
18. Moshkovskii, S. A., Serebryakova, M. V., Kuteykin-Teplyakov, K. B., Tikhonova, O. V. et al., Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics 2005, 5, 3790-3797.
19. Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M. et al., Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004, 109, 726-732.
20. Bozinovski, S., Hutchinson, A., Thompson, M., Macgregor, L. et al., Serum amyloid A is a biomarker of acute exacerbations of COPD. Am. J. Respir. Crit. Care Med. 2007, 177, 269-278.
21. O'Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O. et al., Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res. 2000, 2, 142-144.
22. Tolosano, E., Fagoonee, S., Hirsch, E., Berger, F. G. et al., Enhanced splenomegaly and severe liver inflammation in haptoglobin/ hemopexin double-null mice after acute hemolysis. Blood 2002, 100, 4201-4208.
23. Schanstra, J. P., Bachvarova, M., Neau, E., Bascands, J. L. et al., Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice. Kidney Int. 2007, 72, 442-454.
24. Hewitson, T. D., Martic, M., Kelynack, K. J., Pagel, C. N. et al., Thrombin is a pro-fibrotic factor for rat renal fibroblasts in vitro. Nephron Exp. Nephrol. 2005, 101, e42-e49.
25. Sechi, L. A., Zingaro, L., Catena, C., De Marchi, S., Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events. Thromb. Haemost. 2000, 84, 565-570.
26. Arif, S., Khan, A. S., Khan, A. R., Changes in fibrinogen level in liver cirrhosis. J. Ayub.Med. Coll. Abbottabad. 2002, 14, 19-21.
27. Clarkson, A. R., Seymour, A. E., Jackson, B., Coagulation and renal disease. Med. J. Aust. 1976, 1, 573-578.
28. Wendt, T., Zhang, Y. M., Bierhaus, A., Kriegsmann, J. et al., Tissue factor expression in an animal model of hydrone-phrosis. Nephrol. Dial. Transplant. 1995, 10, 1820-1828.
29. Patel, S., Takagi, K. I., Suzuki, J., Imaizumi, A. et al., RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. J. Am. Soc. Nephrol. 2005, 16, 1977-1984.
30. Lin, S., Chugh, S., Pan, X., Wallner, et al., Identification of up-regulated Ras-like GTPase, Rap1b, by suppression subtractive hybridization. Kidney Int. 2001, 60, 2129-2141.
31. Nagatoya, K., Moriyama, T., Kawada, N., Takeji, M. et al., Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 2002, 61, 1684-1695.
32. Kalantar-Zadeh, K., Mehrotra, R., Fouque, D., Kopple, J. D., Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin. Dial. 2004, 17, 455-465.
33. Liu, K.-J., Shih, N.-Y., The role of enolase in tissue invasion and metastasis of pathogens and tumour cells. J. Canc. Mol. 2007, 3, 45-48.
34. Haugaard, N., Potter, L., Wein, A. J., Levin, R. M., Effect of partial obstruction of the rabbit urinary bladder on malate dehydrogenase and citrate synthase activity. J. Urol. 1992, 147, 1391-1393.
35. Zhang, H., Wada, J., Kanwar, Y. S., Tsuchiyama, Y. et al., Screening for genes up-regulated in 5/6 nephrectomized mouse kidney. Kidney Int. 1999, 56, 549-558.
36. Valkova, N., Yunis, R., Mak, S. K., Kang, K. et al., Nek8 mutation causes overexpression of galectin-1, sorcin, and vimentin and accumulation of the major urinary protein in renal cysts of jck mice. Mol. Cell. Proteomics 2005, 4, 1009-1018.